All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

Heroin addiction is a chronic brain disease characterized by compulsive drug-seeking, drug abuse, physical dependence, tolerance, and relapse \[[@pone.0163668.ref001]\]. Heroin is one of the most commonly used drugs in China. At the end of 2014, a total of 2.955 million drug addicts were registered in China. Opioid drug addicts numbered 1.458 million, 49.3% of whom were heroin users. A total of 9.3 tons of heroin were seized in 2014. The direct economic losses resulting from drug addiction approach CNY 500 billion every year, representing a substantial economic burden to individuals and families. Similarly to other neuropsychiatric diseases, drug addiction results from a combination of genetic and environmental factors \[[@pone.0163668.ref002]\]. Family, adoption, and twin studies have suggested that genetic factors account for 30--60% of the overall variance in the risk of developing drug addiction \[[@pone.0163668.ref003]--[@pone.0163668.ref005]\].

Recently, FAT atypical cadherin 3 (*FAT3*), kinectin 1 (*KTN1*), discs large homolog 2 (*DLG2*) and deleted in colorectal cancer (*DCC*) have been reported to be associated with the function of the human mesolimbic reward system \[[@pone.0163668.ref006]\], which is the neurobiological basis of drug addiction. Cadherin, encoded by the *FAT3* gene, regulates neuronal morphology by affecting cell interactions \[[@pone.0163668.ref007]\], a crucial mechanism of pathological memory formation during drug addiction \[[@pone.0163668.ref008], [@pone.0163668.ref009]\]. The *FAT3* gene affects the volume of the caudoputamen \[[@pone.0163668.ref006]\], which plays important roles in habit formation, motivation, and the mechanism of drug addiction \[[@pone.0163668.ref010]\]. KTN1 is responsible for organelle transport and localization \[[@pone.0163668.ref011]\], and this protein is also closely associated with the formation and quantity of dendritic spines \[[@pone.0163668.ref012]\], which form the common anatomical substrate of drug addiction\[[@pone.0163668.ref009]\]. Another biological function of KTN1 is facilitating vesicle binding with kinesin, this binding is followed by kinesin-driven vesicle fast anterograde transport in axons \[[@pone.0163668.ref013], [@pone.0163668.ref014]\], suggesting that KTN1 is a promising candidate gene involved in drug addiction. Recently, the role of DLG2 has been investigated in a multitude of neuropsychiatric diseases. Genetic variants in *DLG2* affect learning and cognitive flexibility \[[@pone.0163668.ref015]\]. Genetic mapping of habitual substance users has revealed that DLG2 is overexpressed at the neural synapse \[[@pone.0163668.ref016]\]. The *DCC* gene encodes netrin-1 receptor, which affects axon guidance and migration \[[@pone.0163668.ref017]\]. *DCC* has been widely studied in a multitude of neuropsychiatric diseases. Sensitizing amphetamine pretreatment regimens result in selective upregulation of the expression of DCC in the ventral tegmental area of adult rodents \[[@pone.0163668.ref018]\], and *DCC* haploinsufficiency decreases sensitivity to the cocaine mediated enhancement of reward seeking behavior \[[@pone.0163668.ref019]\]. Furthermore, DCC is a regulator of maladaptive responses, such as tolerance, dependence and opioid-induced hyperalgesia to chronic morphine administration \[[@pone.0163668.ref020]\]. On the basis of these findings, these four genes may be important mediators of drug addiction. To the best of our knowledge, the roles of these genes in heroin addiction have not previously been reported.

Variations in gene functional regions may represent the most direct molecular mechanisms of disease\[[@pone.0163668.ref021]\]. The exon sequence can be transcribed into the final mRNA. Variations in exon regions may change the amino acid sequences. The most prominent example is brain-derived neurotrophic factor (*BDNF*), whose rs6265 SNP is directly associated with the clinical phenotype of drug addiction \[[@pone.0163668.ref022], [@pone.0163668.ref023]\]. Variations in promoter affect the efficiency of gene transcription. Variations in intron-exon borders may affect exon recognition and change the attributes of the alternative products \[[@pone.0163668.ref024], [@pone.0163668.ref025]\]. 5'UTRs are DNA regulatory sequences located in the 5'termini of protein-coding genes. These sequences can be transcribed to mRNA, but cannot be translated to protein. 5'UTRs contain a variety of regulatory elements, including the 5'cap, secondary structure, alternative 5'UTRs, internal ribosome entry sites, and upstream open reading frames (uORFs), among others. In general, 5'UTRs primarily regulate transcriptional initiation\[[@pone.0163668.ref026]\]. 3'UTRs are DNA regulatory sequences located downstream of the protein coding sequences, and these sequences primarily regulate gene expression at the post-transcriptional level, including transcriptional stability and cleavage, and polyadenylation, among others \[[@pone.0163668.ref027]\]. Because determining associations between functional polymorphisms and heroin addiction would be meaningful, we used HapMap (Han Chinese population) HCB data to systematically scan the promoter, 5'UTR, 3'UTR, exon, and intron-exon border regions of *FAT3*, *KTN1*, *DLG2* and *DCC*, and 20 SNPs were selected to do association analysis with heroin addiction.

Materials and Methods {#sec002}
=====================

Subjects {#sec003}
--------

A total of 1080 individuals were recruited for the present study. All of these individuals were biologically unrelated individuals of China Han ancestry. Among them, 523 individuals were heroin addiction patients (mean age 45.13±7.270years) recruited from the Methadone Maintenance Treatment (MMT) Program at the Xi'an Mental Health Center between October 2013 and May 2015. At least two senior psychiatrists independently interviewed all patients, and urine testing and the Diagnostic and Statistical Manual of Mental Disorders, fourth revision (DSM-IVR) diagnostic criteria were applied to diagnose opioid addiction. A case vignette was generated to assist with the diagnosis, using a semi-structured interview with questions regarding (a) the age of onset and the duration of heroin use, (b) the quantity of the drug used during this period, (c) the route of administration (i.e., nasal inhalation or injection), (d) whether other substances were used or abused, and (e) comorbidity with any other psychiatric disorder. Participants meeting DSM-IVR criteria for an additional Axis I disorder; with a history of cigarette, alcohol, amphetamine, barbiturate, or benzodiazepine dependence; exhibiting mental illness or neurological diseases; or a history of hematological diseases, seizures, or other chronic physical illnesses were excluded.

The control cohort comprised 557 healthy people (mean age 45.80±10.449 years) recruited from the health examination center at the First Hospital Affiliated with the Medical College of Xi'an Jiao Tong University. The selection criteria were: having no individual history of drug addiction or mental illness, and frequency matching to cases on the basis of gender and age.

All participants provided written informed consent. Our study protocol was approved by the Ethical Committee of Xi'an Mental Health Center, Xi'an, China and the methods were performed in accordance with the approved guidelines.

SNP selection {#sec004}
-------------

A total of 20 SNPs were selected on the basis of the following criteria: (1) location in functional region of the gene, including the promoter region, untranslated regions (UTRs), exons, and intron-exon borders, and (2) minor allele frequencies (MAF) greater than 0.05 on the basis of HapMap. The chromosomal positions of the six SNPs in *KTN1* (rs10146870, rs1138345, rs10483647, rs1951890, rs17128657, and rs945270) were searched from 55554095 to 55706484bp. The chromosomal positions of the six SNPs in *DCC* (rs17753970, rs934345, rs2229080, rs16956878, rs12607853, and rs2292043) were searched from 52338192 to 53536381bp. The chromosomal positions of the four SNPs in *FAT3* (rs10765565, rs4753069, rs2197678, and rs7927604) were searched from 92312328 to 92896960bp. The chromosomal positions of the four SNPs in DLG2 (rs575050, rs2512676, rs17145219, and rs2507850) were searched from 83454513 to 85629270bp. The databases were HapMap and dbSNP (HCB), and the positions of these SNPs are listed in [Table 1](#pone.0163668.t001){ref-type="table"}.

10.1371/journal.pone.0163668.t001

###### Genotypic and allelic frequencies of gene polymorphisms in the control and case group and statistical results.

![](pone.0163668.t001){#pone.0163668.t001g}

  Gene     Variable     Position   MAF     Controls (557)   Cases (523)   *P*-value^a^   *P*-value^b^   *P*-value^c^   OR, 95% CI            
  -------- ------------ ---------- ------- ---------------- ------------- -------------- -------------- -------------- ------------ -------- --------------------
  *FAT3*   rs10765565   Exon17     0.219                                                                0.19           0.712        14.240   
           GG                              345              61.9          321            61.4                          0.849        16.980   0.976,0.764--1.248
           GT                              180              32.3          177            33.8                          0.594        11.880   1.071,0.831--1.381
           TT                              32               5.7           25             4.8                           0.478        9.560    0.824,0.481--1.410
           G allele                        870              78.1          819            78.3                          0.910        18.200   1.012,0.825--1.241
           T allele                        244              21.9          227            21.7                                                
           rs4753069    Exon19     0.291                                                                0.43           0.811        16.220   
           GG                              284              51.0          269            51.4                          0.883        17.660   1.018,0.802--1.293
           GA                              222              39.9          201            38.4                          0.632        12.640   0.942,0.738--1.203
           AA                              51               9.2           53             10.1                          0.586        11.720   1.119,0.747--1.676
           G allele                        790              70.9          739            70.7                          0.892        17.840   0.987,0.820--1.189
           A allele                        324              29.1          307            29.3                                                
           rs2197678    3\' UTR    0.289                                                                0.178          0.432        8.640    
           CC                              275              49.4          277            53.0                          0.238        4.760    1.155,0.909--1.466
           CT                              242              43.4          207            39.6                          0.197        3.940    0.853,0.669--1.087
           TT                              40               7.2           39             7.5                           0.862        17.240   1.041,0.659--1.647
           C allele                        792              71.1          761            72.8                          0.392        7.840    1.086,0.900--1.310
           T allele                        322              28.9          285            27.2                                                
           rs7927604    3\' UTR    0.376                                                                0.69           0.653        13.060   
           AA                              219              39.3          201            38.4                          0.765        15.300   0.963,0.754--1.231
           AG                              257              46.1          254            48.6                          0.425        8.500    1.102,0.868--1.400
           GG                              81               14.5          68             13.0                          0.463        9.260    0.878,0.621--1.243
           A allele                        695              62.4          656            62.7                          0.875        17.500   1.014,0.852--1.207
           G allele                        419              37.6          390            37.3                                                
  *KTN1*   rs10146870   5\' near   0.403                                                                0.33           0.562        11.240   
           GG                              204              36.6          201            38.4                          0.540        10.800   1.080,0.844--1.382
           GC                              257              46.1          244            46.7                          0.866        17.320   1.021,0.804--1.297
           CC                              96               17.2          78             14.9                          0.300        6.000    0.842,0.608--1.166
           G allele                        665              59.7          646            61.8                          0.326        6.520    1.090,0.917--1.296
           C allele                        449              40.3          400            38.2                                                
           rs1138345    5\' UTR    0.367                                                                0.21           0.314        6.280    
           TT                              230              41.3          229            43.8                          0.407        8.140    1.107,0.870--1.410
           GT                              245              44.0          233            44.6                          0.852        17.040   1.023,0.805--1.301
           GG                              82               14.7          61             11.7                          0.138        2.760    0.765,0.536--1.091
           T allele                        705              63.3          691            66.1                          0.178        3.560    1.129,0.946--1.347
           G allele                        409              36.7          355            33.9                                                
           rs10483647   Intron10   0.291                                                                0.86           0.949        18.980   
           AA                              281              50.4          269            51.4                          0.746        14.920   1.040,0.819--1.321
           AG                              228              40.9          210            40.2                          0.794        15.880   0.968,0.759--1.235
           GG                              48               8.6           44             8.4                           0.904        18.080   0.974,0.635--1.494
           A allele                        790              70.9          748            71.5                          0.760        15.200   1.029,0.854--1.240
           G allele                        324              29.1          298            28.5                                                
           rs1951890    Intron18   0.375                                                                0.64           0.234        4.680    
           AA                              220              39.5          218            41.7                          0.465        9.300    1.095,0.859--1.396
           AG                              256              46.0          247            47.2                          0.677        13.540   1.055,0.828--1.337
           GG                              81               14.5          58             11.1                          0.090        1.800    0.733,0.511--1.051
           A allele                        696              62.5          683            65.3                          0.173        3.460    1.130,0.948--1.347
           G allele                        418              37.5          363            34.7                                                
           rs17128657   Intron20   0.338                                                                0.028          0.061        1.220    
           AA                              256              46.0          249            48.2                          0.587        11.740   1.069,0.841--1.357
           AT                              226              40.6          222            42.9                          0.532        10.640   1.080,0.848--1.376
           TT                              75               13.5          46             8.9                           0.015        0.300    0.620,0.420--0.914
           A allele                        738              66.2          720            69.6                          0.093        1.860    1.168,0.974--1.401
           T allele                        376              33.8          314            30.4                                                
           rs945270     3\' near   0.190                                                                0.96           0.018        0.360    
           GG                              365              65.5          310            59.3                          0.034        0.680    0.766,0.598--0.980
           GC                              172              30.9          177            33.8                          0.298        5.960    1.145,0.887--1.478
           CC                              20               3.6           36             6.9                           0.015        0.300    1.985,1.134--3.475
           G allele                        902              81.0          797            76.2                          0.007        0.140    0.752,0.612--0.925
           C allele                        212              19.0          249            23.8                                                
  *DLG2*   rs575050     5\' near   0.409                                                                0.45           0.750        15.000   
           TT                              190              34.1          186            35.6                          0.616        12.320   1.066,0.830--1.370
           TG                              278              49.9          249            47.6                          0.450        9.000    0.912,0.718--1.158
           GG                              89               16.0          88             16.8                          0.707        14.140   1.064,0.771--1.468
           T allele                        658              59.1          621            59.4                          0.886        17.720   1.013,0.853--1.202
           G allele                        456              40.9          425            40.6                                                
           rs2512676    3\' UTR    0.317                                                                0.69           0.146        2.920    
           TT                              262              47.0          260            49.7                          0.379        7.580    1.113,0.877--1.413
           TG                              237              42.5          226            43.2                          0.826        16.520   1.027,0.807--1.308
           GG                              58               10.4          37             7.1                           0.053        1.060    0.655,0.426--1.008
           T allele                        761              68.3          746            71.3                          0.128        2.560    1.153,0.960--1.387
           G allele                        353              31.7          300            28.7                                                
           rs17145219   3'UTR      0.230                                                                0.39           0.066        1.320    
           CC                              334              60.0          338            64.6                          0.114        2.280    1.220,0.953--1.561
           CG                              190              34.1          168            32.1                          0.488        9.760    0.914,0.709--1.178
           GG                              33               5.9           17             3.3                           0.037        0.740    0.533,0.293--0.970
           C allele                        858              77.0          844            80.7                          0.037        0.740    1.247,1.013--1.534
           G allele                        256              23.0          202            19.3                                                
           rs2507850    3\' near   0.311                                                                0.52           0.146        2.920    
           GG                              268              48.1          261            49.9                          0.557        11.140   1.074,0.846--1.364
           GA                              232              41.7          226            43.2                          0.604        12.080   1.066,0.837--1.357
           AA                              57               10.2          36             6.9                           0.050        1.000    0.648,0.419--1.002
           G allele                        768              68.9          748            71.5                          0.192        3.840    1.131,0.940--1.360
           A allele                        346              31.1          298            28.5                                                
  *DCC*    rs17753970   5\' near   0.499                                                                0.19           0.311        6.220    
           AA                              132              23.7          145            27.7                          0.130        2.600    1.235,0.940--1.624
           AG                              294              52.8          259            49.5                          0.284        5.680    0.878,0.691--1.114
           GG                              131              23.5          119            22.8                          0.766        15.320   0.958,0.722--1.271
           A allele                        558              50.1          549            52.5                          0.266        5.320    1.101,0.930--1.303
           G allele                        556              49.9          497            47.5                                                
           rs934345     5\' near   0.286                                                                0.17           0.021        0.420    
           GG                              277              49.7          304            58.1                          0.006        0.120    1.403,1.103--1.784
           GC                              241              43.3          187            35.8                          0.012        0.240    0.730,0.571--0.932
           CC                              39               7.0           32             6.1                           0.558        11.160   0.866,0.534--1.404
           G allele                        795              71.4          795            76.0                          0.014        0.280    1.271,1.048--1.541
           C allele                        319              28.6          251            24.0                                                
           rs2229080    Exon3      0.497                                                                0.77           0.195        3.900    
           CC                              139              25.0          125            23.9                          0.687        13.740   0.944,0.715--1.247
           GC                              282              50.6          245            46.8                          0.214        4.280    0.859,0.677--1.091
           GG                              136              24.4          153            29.3                          0.073        1.460    1.280,0.977--1.677
           C allele                        560              50.3          495            47.3                          0.171        3.420    1.125,0.950--1.332
           G allele                        554              49.7          551            52.7                                                
           rs16956878   3\' UTR    0.443                                                                0.24           0.0001       0.002    
           CC                              180              32.3          112            21.5                          0.0001       0.002    0.571,0.434--0.751
           TC                              261              46.9          260            50.0                          0.348        6.960    1.121,0.883--1.424
           TT                              116              20.8          148            28.5                          0.004        0.080    1.500,1.135--1.984
           C allele                        621              55.7          484            46.5                          0.00002      0.0004   1.447,1.221--1.715
           T allele                        493              44.3          556            53.5                                                
           rs12607853   3\' UTR    0.443                                                                0.20           0.0003       0.006    
           CC                              180              32.3          113            21.7                          0.0001       0.002    0.577,0.439--0.759
           CT                              260              46.7          267            51.3                          0.151        3.020    1.191,0.938--1.513
           TT                              117              21.0          140            26.9                          0.026        0.520    1.375,1.038--1.821
           C allele                        620              55.7          493            47.4                          0.0001       0.002    1.393,1.175--1.650
           T allele                        494              44.3          547            52.6                                                
           rs2292043    3\' UTR    0.425                                                                0.16           0.001        0.020    
           TT                              192              34.5          223            42.9                          0.006        0.120    1.413,1.105--1.807
           TC                              256              46.0          235            45.2                          0.735        14.700   0.959,0.755--1.219
           CC                              109              19.6          62             11.9                          0.001        0.020    0.553,0.394--0.775
           T allele                        640              57.5          681            65.5                          0.0001       0.002    1.405,1.180--1.673
           C allele                        474              42.5          359            34.5                                                

*P*-value ^a^ for Hardy-Weinberg equilibrium in controls.

*P*-value ^b^ for genotype and allele frequency difference.

*P*-value ^c^ for *P*-value ^b^ adjusted by Bonferroni correction.

Genotyping {#sec005}
----------

Peripheral blood samples from the enrolled subjects were collected in EDTA-coated tubes. Genomic DNA was extracted from blood leukocytes by using E.Z.N.A.^™^ Blood DNA Midi Kit (Omega Bio-Tek, Norcross, GA, USA) according to the manufacturer's instructions. A total of 20 SNPs were genotyped by using SNaPshot SNP technology. A segment of DNA surrounding each SNP (151--368 bp) was amplified in a 10-μl PCR reaction containing 1XHotStarTaq buffer, 3.0 mM Mg^2+^, 0.3 mM dNTPs, 1 U of HotStarTaq polymerase (Qiagen Inc., USA), 1 μl of DNA and 1 μl of each PCR primer. The PCR program included an initial cycle at 95°C for 2 min, 11 cycles at 94°C for 20 s, 65°C for 40 s, and 72°C for 90 s, 24 cycles at 94°C for 20 s, 59°C for 30 s, and 72°C for 90 s, with a final cycle at 72°C for 2 min, and an indefinite hold at 4°C. To purify the PCR products, 5 U of shrimp alkaline phosphatase (SAP) enzyme and 2 U of Exonuclease I (Exo I) were mixed with 10 μl of the PCR product, incubated for 1 hour at 37°C and inactivated for 15 min at 75°C. The purified PCR products were used in a SNaPshot multiple single-base extension reaction. The extension reaction system (10 μl) contained 5 μl of the SNaPshot Multiplex Ready Reaction Mix (Applied Biosystems Co Ltd., CA, USA), 2 μl of the purified PCR product, 1 μl of the extension reaction primers, and 2 μl of ultrapure water. The PCR program initiated at 96°C for 1 min, and this was followed by 28 cycles of 96°C for 10 s, 55°C for 5 s, and 60°C for 30 s, and an indefinite hold 4°C. The products were purified after incubation with 1 U of SAP for 1 hour at 37°C, and this was followed by inactivation for 15 minutes at 75°C. Subsequently, 0.5 μl of the purified product was added to 0.5 μl of 120 Liz SIZE STANDARD (Applied Biosystems, Foster City, CA, USA) and 9 μl of Hi-Di (Applied Biosystems, Foster City, CA, USA), and this was followed by sequencing on an ABI3130XL Sequencer (Applied Biosystems, Foster City, CA, USA) after degeneration at 95°C for 5 minutes. The primary data were analyzed using GeneMapper 4.1 (AppliedBiosystems Co., Ltd., USA). The genotypes were determined on the basis of the nucleotide present at the SNP site, visualized as either one or two color peaks.

For quality control, 5% of the subjects (54 subjects) were randomly selected and blinded researchers conducted genotyping again, with a reproducibility of 100%.

Expression quantitive trait locus analysis {#sec006}
------------------------------------------

The mRNA expression level and genotype data for significant SNPs were received from the SNPexp database (<http://tinyurl.com/snpexp>)\[[@pone.0163668.ref028]\]. The HapMap version for the genotype was HapMap2r23 unfiltered 3.96 million SNPs. The data form RNA expression levels were obtained from transcripts of lymphoblastoid cell lines from the same 45 unrelated Han Chinese individuals in Beijing. The correlations between the genotype and mRNA expression levels of significant SNPs were calculated by using linear regression and the Wald test.

Statistical analysis {#sec007}
--------------------

The genotype and allele frequencies of each individual polymorphism and the Hardy-Weinberg equilibrium (HWE) of the control and case groups were calculated by using the chi-square test. The associations between polymorphisms or other categorical variables with heroin addiction were assessed by using Pearson\'s Chi-square test. Continuous variables, such as the dose of heroin used and the age of heroin addiction onset, were analyzed using a correlate test. *P* values were calculated on the basis of the codominance or dominance of the rare allele, or the heterosis and recessive models of rare allele inheritance.

We computed pairwise LD statistics (D' and r^2^) and haplotype frequencies using Haploview 4.0 (Broad Institute of MIT and Harvard, Cambridge, MA). We constructed haplotype blocks based on the criteria of Gabriel et al \[[@pone.0163668.ref029]\]. When the frequency of the haplotype was less than 5%, this value was excluded from the statistic analysis. We used PHASE 2.1.1 \[[@pone.0163668.ref030]\] software to verify the composition and frequency of positive haplotypes and to conduct permutation tests.

We analyzed the gene-gene interaction using Multifactor Dimensionality Reduction(<http://sourceforge.net/projects/mdr/>) which identifies high dimensional gene-gene interactions\[[@pone.0163668.ref031]\].

*P* values are presented as two-sided, and *p*\<0.05 was considered statistically significant. We used Bonferroni's correction to adjust the test level, and the *p* value was multiplied by all 20 loci or the haplotypes of each gene. All statistical analyses were conducted using SPSS 20.0 software (SPSS Inc., Chicago, IL, USA).

Power analysis {#sec008}
--------------

A sufficient sample size was required in this genetics study \[[@pone.0163668.ref032]\]. Thus, we conducted a power analysis using a Power and Sample Size Program (<http://biostat.mc.vanderbilt.edu/wiki/Main/PowerSampleSize>).

Results {#sec009}
=======

No significant deviation from HWE was observed for any of the SNPs in the case group. In the control group, the rs17128657 SNP statistically deviated from HWE (*p* = 0.028). Five blocks were identified in the linkage disequilibrium (LD) analysis of the case and control data. For the *KTN1* gene, block 1 contained five SNPs (rs17128657, rs1951890, rs10483647, rs1138345 and rs10146870). For the *DLG2* gene, block 1 contained three SNPs (rs2507850, rs2512676 and rs17145219). For the *FAT3* gene, block 1 contained two SNPs (rs10765565 and rs4753069). For the *DCC* gene, block 1 contained two SNPs (rs934345 and rs17753970), and block 2 contained three SNPs (rs2292043, rs12607853 and rs16956878) ([Fig 1](#pone.0163668.g001){ref-type="fig"}). The distributions, frequencies and statistical analyses of the genotype, allele, and haplotype are provided in Tables [1](#pone.0163668.t001){ref-type="table"} and [2](#pone.0163668.t002){ref-type="table"}.

![LD plot of the 20 SNPs in four genes in the control (left) and case (right) groups.\
(a) LD plot of the 4 SNPs of the *FAT3* gene in the control (left) and case (right) groups. (b) LD plot of the 4 SNPs of *DLG2* gene in the control (left) and case (right) groups. (c) LD plot of the 6 SNPs of the *KTN1* gene in the control (left) and case (right) groups. (d) LD plot of the 6 SNPs of the *DCC* gene in control (left) and case (right) groups. The values in squares are the D' calculated using pair-wise analyses. Empty squares indicate D' = 1 (i.e. complete LD between a pair of SNPs).](pone.0163668.g001){#pone.0163668.g001}
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###### The frequencies of haplotypes in the four genes and their associations with the risk of heroin addiction.

![](pone.0163668.t002){#pone.0163668.t002g}

  Gene     Block    Haplotype   Controls(557)   Cases(523)   *P*-value^a^   *P*-value^b^   OR, 95% CI           
  -------- -------- ----------- --------------- ------------ -------------- -------------- ------------ ------- --------------------
  *KTN1*   block1   G-T-A-A-A   171             30.7         169            32.3           0.568        1.704   1.078,0.833--1.393
                                386             69.3         354            67.7                                
                    C-G-A-G-T   169             30.3         139            26.6           0.171        0.513   0.831,0.638--1.083
                                388             69.7         384            73.4                                
                    G-T-G-A-A   155             27.8         147            28.1           0.919        2.757   1.014,0.777--1.323
                                402             72.2         376            71.9                                
  *DLG2*   block1   G-T-C       380             68.2         370            70.8           0.368        1.104   1.126,0.869--1.460
                                177             31.8         153            29.3                                
                    A-G-G       127             22.8         98             18.7           0.100        0.300   0.781,0.581--1.049
                                430             77.2         425            81.3                                
                    A-G-C       46              8.3          49             9.4            0.520        1.560   1.148,0.754--1.750
                                511             91.7         474            90.6                                
  *FAT3*   block1   G-G         273             49.0         257            49.1           0.967        2.901   1.005,0.792--1.276
                                284             51.0         266            50.9                                
                    G-A         162             29.1         153            29.3           0.951        2.853   1.008,0.775--1.311
                                395             70.9         370            70.8                                
                    T-G         122             21.9         112            21.4           0.846        2.538   0.972,0.727--1.298
                                435             78.1         411            78.6                                
  *DCC*    block1   G-A         279             50.1         275            52.6           0.413        1.239   1.105,0.870--1.403
                                278             49.9         248            47.4                                
                    C-G         159             28.6         126            24.1           0.097        0.291   0.794,0.605--1.043
                                398             71.5         397            75.9                                
                    G-G         119             21.4         123            23.5           0.396        1.188   1.132,0.850--1.507
                                438             78.6         400            76.5                                
  *DCC*    block2   T-T-T       246             44.2         273            52.2           0.008        0.024   1.381,1.086--1.754
                                311             55.8         250            47.8                                
                    C-C-C       237             42.6         175            33.5           0.002        0.006   0.679,0.530--0.870
                                320             57.5         348            66.5                                
                    T-C-C       74              13.3         67             12.8           0.817        2.451   0.959,0.673--1.367
                                483             86.7         456            87.2                                

*P*-value^a^ based on comparison of frequency distribution of all haplotypes for the combination of SNPs

*P-*value^b^ for P-value^a^ adjusted by Bonferroni correction.

For the *DCC* gene, the rs16956878 and rs12607853 genotypes were strongly associated with heroin addiction (*p* = 0.002, and *p* = 0.006, respectively). The T allele frequencies of rs16956878 (*p* = 0.0004, odds ratio \[OR\] = 1.447, 95% confidence interval\[CI\] = 1.221--1.715) and rs12607853 (*p* = 0.002, OR = 1.393, 95%CI = 1.175--1.650) were significantly higher in the case group than in the control subjects. A significant difference was also observed in the distribution of the genotype frequency for rs2292043 between the case and control groups (*p* = 0.020). Compared with the control group, the case group exhibited a lower frequency of the C allele (*p* = 0.002, OR = 1.405, 95% CI = 1.180--1.673). For the KTN1 gene, addiction cases had a significantly higher frequency of the C allele than the control group at rs945270, but was not significant after Bonferroni correction (*p* = 0.140, OR = 0.752, 95%CI = 0.612--0.925). The sample size showed a 79%-91% power to detect associations with heroin addiction, with a presumed OR of 1.5, alpha value of 5%, and MAF ranging from 0.190 to 0.497.

In block 2 of *DCC* (rs2292043, rs12607853 and rs16956878), the frequency of the T-T-T haplotype was significantly higher than that in the control group (*p* = 0.024, OR = 1.381, 95% CI = 1.086--1.754), and fewer C-C-C haplotypes (*p* = 0.006, OR = 0.679, 95% CI = 0.530--0.870) were observed in the case group. The frequencies of these haplotypes in block 2 were similar to those obtained using PHASE ([S1 Table](#pone.0163668.s003){ref-type="supplementary-material"}). The *p* value was adjusted by using the 1000 permutations test (*p* = 0.026). On the basis of the results, we selected *DCC* rs16956878 as a representative of rs2292043, rs12607853 and rs16956878 for subsequent analyses.

We analyzed the mRNA expression level and genotype data for *DCC* rs16956878. The mRNA expression levels of subjects with TT and CC genotypes were similar, and showed no significant differences ([S2 Table](#pone.0163668.s004){ref-type="supplementary-material"}).

The demographic and addiction characteristics were analyzed with respect to *DCC* rs16956878 ([Table 3](#pone.0163668.t003){ref-type="table"}). Compared with the CC genotype, the TT and TC genotypes were more likely to be associated with more varied routes of heroin administration. The TT and TC genotypes, compared with the CC genotype, were more likely to be associated with heroin use through sniffing, smoking, intravenous injection, or compound delivery methods.

10.1371/journal.pone.0163668.t003

###### Demographic and addiction characteristics of *DCC* SNP rs16956878.

![](pone.0163668.t003){#pone.0163668.t003g}

  Variable                                                                   *DCC* rs16956878               
  -------------------------------------------------------------------------- ------------------ ----------- -----------
  Age (year)                                                                 46.7±6.19          46.1±5.77   45.7±5.84
  Gender (%)                                                                                                
  Male                                                                       21.3               49.8        28.9
  Female                                                                     33.3               47.6        19.1
  Occupation (%)                                                                                            
  Employed                                                                   19.2               54.1        26.7
  Unemployed                                                                 23.1               47.4        29.5
  Marital status (%)                                                                                        
  Unmarried                                                                  19.8               51.9        28.3
  Married                                                                    23.0               48.0        29.0
  Divorced or widowed                                                        16.7               56.3        27.1
  Route of heroin administration (%)[^a^](#t003fn001){ref-type="table-fn"}                                  
  Sniffed or smoked                                                          17.4               57.1        25.5
  Injection via vein                                                         21.9               51.7        26.5
  Injection via muscle                                                       36.4               36.4        27.3
  Compound                                                                   26.5               27.9        45.6
  Per-usage (gram)                                                           0.3±0.14           0.3±0.34    0.3±0.18
  Onset age (year)                                                           29.1±6.68          29.4±6.41   28.6±6.73

^a^ Associated with route of heroin administration of rs16956878, p = 0.003.

The number that follows the ± sign is a standard deviation (s.d.).

The results of the gene-gene interaction using MDR are listed in [Table 4](#pone.0163668.t004){ref-type="table"}. The testing balance accuracy and cross validation consistency were the highest in models of rs12607853, rs2229080, and rs934345 ([S1 Fig](#pone.0163668.s002){ref-type="supplementary-material"}). Because it had the highest cross validation consistency and testing balance accuracy, the three-locus model was considered to be the optimal model.

10.1371/journal.pone.0163668.t004

###### The results of gene-gene interactions using MDR.

![](pone.0163668.t004){#pone.0163668.t004g}

  Model                                     Training Bal. Acc   Testing Bal. Acc   CV Consistency
  ----------------------------------------- ------------------- ------------------ ----------------
  rs16956878                                0.5545              0.5526             8/10
  rs16956878 rs934345                       0.5802              0.5499             6/10
  rs12607853 rs2229080 rs934345             0.6141              0.5824             10/10
  rs12607853 rs2229080 rs2512676 rs934345   0.6618              0.5721             7/10

Discussion {#sec010}
==========

Addiction is a disease resulting from interactions between genes and the environment \[[@pone.0163668.ref033]\]. The genetic susceptibility of heroin addiction primarily refers to the likelihood of individuals to use or become addicted to heroin because of differences in genetic factors \[[@pone.0163668.ref034]--[@pone.0163668.ref036]\]. Family, adoption, and twin studies have suggested that genetic factors account for 30--60% of the overall variance in the risk of developing drug addiction \[[@pone.0163668.ref003], [@pone.0163668.ref004]\]. The aim of our research was to identify additional genetic markers of heroin addiction through a case-control study. In addition to genetics, the substances effect is also an important factor leading to heroin addiction \[[@pone.0163668.ref037]\]. Indeed, the effect is different among the same people receiving different doses of heroin in a certain range \[[@pone.0163668.ref038]\]. However, not all people exposed to heroin will become addicted to this drug\[[@pone.0163668.ref037]\]. Our heroin addicts were recruited from the MMT Program and were diagnosed with heroin addiction. Our healthy controls were never self-exposed to heroin. Thus, our results should indicate that some subjects are more likely to become addicted to heroin, despite the effects of environmental factors.

*DCC* is involved in axon guidance pathways, and its genetic variants influence the structure of the human mesolimbic reward system \[[@pone.0163668.ref006]\], which plays a key role in drug addiction. Our study provides direct evidence that polymorphisms of the *DCC* gene are associated with heroin addiction in the Chinese Han population.

In the present study, we observed that the T alleles of the *DCC* SNPs rs16956878 and rs12607853 were strongly associated with an increased risk of heroin addiction, whereas the C allele of *DCC* rs2292043 was associated with a decreased risk of heroin addiction, and these variants are located within the *DCC* 3' UTR. Moreover, we observed a significant increase in the T-T-T haplotype (rs2292043- rs12607853- rs16956878) in heroin addicts compared with the members of the control group. These results suggest that the subjects carrying the T-T-T haplotype are more likely to become addicted to heroin. The 3' UTR of a gene contains a number of regulatory sequences that are targets of a variety of regulatory molecules, including RNA binding proteins (RBPs) and small noncoding RNAs (ncRNAs), which recognize small cis-elements present in the 3' UTRs and determine the stability, cellular localization, and translation of the encoded mRNA \[[@pone.0163668.ref039], [@pone.0163668.ref040]\]. Among these regulatory molecules, microRNAs down-regulate genes and promote RNA cleavage through perfect base pairing with a target sequence \[[@pone.0163668.ref027]\]. By searching the MirSNP database \[[@pone.0163668.ref041]\], we observed that when rs12607853 allele changes from T to C, the mRNA of *DCC* can combine with hsa-miR-141-3p, and decrease *DCC* gene expression. When the rs2292043 allele changes from T to C, the mRNA of *DCC* can combine with hsa-miR-141-3689d, and decrease *DCC* gene expression. When the rs16956878 allele changes from T to C, the combined effect of the mRNA of *DCC* and hsa-miR-4666a-5p increases, thereby decreases *DCC* gene expression. Thus, in the heroin group, the higher frequency of T than C alleles, led to increased RNA expression. Our results are in agreement with the previous animal experimental conclusions. *DCC* haploinsufficiency mice showed blunted sensitivity to cocaine-mediated enhancement of reward seeking behavior \[[@pone.0163668.ref019]\]. We conducted an eQTL analysis of the mRNA expression level and examined the genotype data for *DCC* rs16956878 obtained from the SNPexp database. The mRNA expression levels of the subjects with TT and CC genotypes showed no significant differences. Because the RNA expression level and genotype data were obtained from only 45 unrelated individuals, the results may reflect the small sample size. Therefore, additional studies on the mRNA expression level of *DCC* and examination of the genotype data for rs16956878 with larger sample sizes are urgently needed. Grant et al. have reported an association between schizophrenia and the rs2270954 polymorphism in the 3' UTR of the *DCC* gene \[[@pone.0163668.ref042]\]. Peng et al have reported an association between schizophrenia and the rs2229080 polymorphism in the exon 3 of the *DCC* gene \[[@pone.0163668.ref043]\]. These results further support an important role for DCC in neuropsychiatric diseases. To confirm the link between the *DCC* gene and addiction, rs16956878 was analyzed, and the results suggested an association with the route of heroin administration. The rs16956878 TT and TC genotypes were associated with increased variance in the route of heroin administration and therefore might be associated with easier access to drugs. DCC is involved in axon guidance pathways and plays a critical functional role in the organization of brain development and in adult neuroplasticity \[[@pone.0163668.ref017], [@pone.0163668.ref044]\]. These results suggest that the *DCC* gene may contribute to the genetic basis of individual differences in susceptibility to heroin addiction.

*KTN1* encodes the protein kinectin, which is primarily found in the endoplasmic reticulum in the dendrites and thesoma of neurons \[[@pone.0163668.ref012]\]. KTN1 plays a critical role in the regulation of neuronal cell shape, spreading, and migration through kinectin--kinesin interactions \[[@pone.0163668.ref045]\]. Disrupting the kinectin--kinesin interaction results in a morphological change to a rounded cell shape and reduced cell spreading and migration\[[@pone.0163668.ref045]\], which decreases the polarization of the neuronal architecture and the cellular complexity essential for neuronal functions \[[@pone.0163668.ref046]\]. Therefore, KTN1 may affect the density or complexity of the dendritic spines in drug addicts, thereby causing brain region-specific changes in the density of these structures\[[@pone.0163668.ref047]\]. The rs945270 SNP is located 50 kb downstream of the *KTN1* gene of 14q22.3. The C allele of rs945270 increases the expression of *KTN1* in the frontal cortex and putamen \[[@pone.0163668.ref048], [@pone.0163668.ref049]\]. In the present study, we identified a significantly higher C allele frequency in the heroin addiction group, although this result was not significant after correction. It has been suggested that subjects with the C allele in addicts might exhibit higher *KTN1* expression in the frontal cortex and putamen. Interestingly, amphetamine, cocaine and nicotine increase the spine density on the apical dendrites of the medial prefrontal cortex \[[@pone.0163668.ref050]--[@pone.0163668.ref052]\] and morphine significantly increases dendritic spine density in the orbital frontal cortex of adult rats\[[@pone.0163668.ref047]\]. Thus, KTN1 may increase the density or complexity of dendritic spines in the frontal cortices of heroin addicts.

FAT3 is the human homolog of *Drosophila* FAT which inhibits Yokie through phosphorylation and subsequently activates the expanded-Hippo-Warts signaling cascade\[[@pone.0163668.ref053]\]. Phosphorylation of yes-associated protein 1(YAP1) in Hippo signaling inhibits the Wnt signaling cascade through interactions with β-catenin \[[@pone.0163668.ref054]\]. The cell polarity protein complex, Dlg/Lgl/Scrib affects the cell-cell contacts, thus leading to the deregulation of the actin cytoskeleton through interactions with Hippo pathways\[[@pone.0163668.ref055]\]. Netrin and Wnt signaling pathways play important roles in axon guidance\[[@pone.0163668.ref056]\]. Netrin signaling is primarily responsible for dorso-ventral (D/V)-graded distributions and Wnt signaling is primarily responsible for antero-posterior (A/P) distributions\[[@pone.0163668.ref057]\]. Kinesin-1 acts with DCC in sensory neuron position \[[@pone.0163668.ref058]\]. Thus, we speculated that these four genes might be involved in Hippo and/or Wnt signaling pathways. Studies have shown that the Wnt pathway regulates the susceptibility of chronic stress and addiction through the regulation of the differentiation of dopamine neurons in the mesolimbic reward system \[[@pone.0163668.ref059], [@pone.0163668.ref060]\]. Unfortunately, we did not obtain direct evidence from the KEGG pathway and PATHWAY STUDIO databases. The SNPs in the optimal model of gene-gene interaction were rs12607853, rs2229080, and rs934345, all of which are located in the *DCC* gene and no gene-gene interactions were detected. Thus, a pathway study of these genes would be meaningful in the future.

Conclusion {#sec011}
==========

To the best of our knowledge, this is the first report demonstrating an association between heroin addiction and functional polymorphisms within the *DCC* gene in a homogeneous sampling population. However, further replication or validation across populations should be considered in the future. Moreover, studies of these polymorphisms and their expression are warranted to further the understanding of how these variants influence the expression and induction of these genes. These studies should help to elucidate the pathogenesis of heroin addiction and may offer a basis for the diagnosis and treatment of addiction.
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###### Genetic data in this study.

(XLSX)
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Click here for additional data file.

###### Optimal models determined by using MDR.

Graphical model of rs12607853, rs2229080, and rs934345 (for SNP: 0 = no risk alleles, 1 = 1 risk allele, and 2 = 2 risk alleles). In each small square, the numbers represent the number of cases (left) and controls (right). Dark-shading for each square represents a high risk of disease, whereas light shading indicates a low risk of disease.

(TIF)
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Click here for additional data file.

###### Haplotype frequencies estimated by using PHASE.
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###### *DCC* mRNA expression in the genotypes of rs16956878.
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Click here for additional data file.
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